Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists

Citations Over TimeTop 16% of 2007 papers

Abstract

Pursuing our earlier efforts in the himbacine-based thrombin receptor antagonist area, we have synthesized a series of compounds that incorporate heteroatoms in the C-ring of the tricyclic motif. This effort has resulted in the identification of several potent heterocyclic analogs with excellent affinity for the thrombin receptor. Several of these compounds demonstrated robust inhibition of platelet aggregation in an ex vivo model in cynomolgus monkeys following oral administration. A detailed profile of 28b, a benchmark compound in this series, with a Ki of 4.3 nM, is presented.

Related Papers

• → Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor.(1992)148 cited
• → Surface thrombomodulin modulates thrombin receptor responses on vascular smooth muscle cells(1996)38 cited
• → Thrombin-induced mitogenesis in cultured aortic smooth muscle cells requires prolonged thrombin exposure(1995)53 cited
• → "Mirror image" antagonists of thrombin-induced platelet activation based on thrombin receptor structure.(1992)53 cited
• → Development and Current Applications of Thrombin-specific Inhibitors(2001)11 cited